(3S)-4-Amino-3-hydroxybutanoic acid(CAS: 7013-05-0)

Regulatory guidelines for (3S)-4-Amino-3-hydroxybutanoic acid (CAS: 7013-05-0) include GHS classification, which categorizes it under health hazards. REACH regulations in the European Union require suppliers to register the substance, while FDA/EPA have specific requirements for its handling and disposal in pharmaceutical and industrial applications. Companies must adhere to these guidelines to ensure compliance and safety.

While (3S)-4-Amino-3-hydroxybutanoic acid (CAS: 7013-05-0) is a specific compound, alternatives include similar amino acids and derivatives. Common substitutes for synthesis purposes include (S)-2-Aminobutyric acid and other related amino acids. Researchers often explore isomers and structural analogs as alternatives, depending on the desired properties and end use.

The market trend for (3S)-4-Amino-3-hydroxybutanoic acid (CAS: 7013-05-0) is driven by its applications in pharmaceuticals and research. Recent research focuses on its role in neurodegenerative diseases and its potential as a therapeutic agent. Market trends show increasing demand, particularly in the development of new drug candidates and studies related to its biological activities.

Waste containing (3S)-4-Amino-3-hydroxybutanoic acid (CAS: 7013-05-0) should be collected and stored in appropriate containers, ensuring proper labeling. For waste disposal, incineration is a common method, but professional waste disposal services are recommended to ensure compliance with local environmental regulations. Companies should follow best practices to minimize environmental impact and ensure safety.